Clinical Trial Site

Paris 75877

5 studies enrolling now · 20 studies all time

What they study most

ALA Dehydratase Deficient Porphyria (ADP), ANCA-Associated Vasculitis, Acute Hepatic Porphyria, Acute Intermittent Porphyria, Acute Porphyria, Advanced Breast Cancer, Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, Hereditary, Amyloidosis, Hereditary, Transthyretin-Related, Atypical Hemolytic Uremic Syndrome (aHUS), Breast Cancer

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD — Recruiting now
• Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer — Completed
• BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) — Running, not enrolling
• A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Enrolling by invitation
• HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Running, not enrolling
• Long Term Extension Study in Patients With Primary Hyperoxaluria — Running, not enrolling
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1 — Completed
• A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 — Completed
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 — Completed
• ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) — Completed
• Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed
• A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria — Completed
• Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery — Stopped early
• EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) — Completed
• ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) — Completed